Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Ciba-Geigy
|
| gptkbp:activities |
inhibits fungal squalene epoxidase
|
| gptkbp:approves |
gptkb:1992
gptkb:FDA |
| gptkbp:brand |
terbinafine hydrochloride
|
| gptkbp:clinical_trial |
patient satisfaction
adverse effects monitoring safety in long-term use comparison with other antifungals efficacy in onychomycosis |
| gptkbp:contraindication |
alcohol consumption
liver disease pregnancy breastfeeding allergy to terbinafine |
| gptkbp:dosage_form |
oral
topical |
| gptkbp:duration |
2 to 6 weeks
up to 12 weeks for nail infections |
| gptkbp:formulation |
gptkb:tablet
gptkb:skincare_product spray |
| https://www.w3.org/2000/01/rdf-schema#label |
Lamisil
|
| gptkbp:ingredients |
terbinafine
|
| gptkbp:interacts_with |
certain antidepressants
certain antifungal medications certain blood thinners certain antihistamines |
| gptkbp:is_available_on |
gptkb:drug
prescription medication |
| gptkbp:is_used_for |
treating fungal infections
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:marketed_as |
many countries
|
| gptkbp:serves |
athlete's foot
ringworm jock itch nail fungus |
| gptkbp:side_effect |
headache
nausea abdominal pain diarrhea itching skin rash liver function abnormalities taste disturbances |
| gptkbp:storage |
room temperature
away from moisture |